Literature DB >> 16036803

Poliovirus type 1 infection of murine PRNP-knockout neuronal cells.

Andreina Baj1, Alessia Bettaccini, Takuya Nishimura, Takashi Onodera, Antonio Toniolo.   

Abstract

Transfection of the prion protein gene (Prnp) into prion-deficient mouse cells was shown to reduce the replication of coxsackievirus B3, an enterovirus. Because mice can be susceptible to poliovirus infection by parenteral routes, the authors tested the susceptibility to poliovirus-1 (PV-1) of a panel of murine neuronal cell lines differing in their ability to express Prnp. The investigated cell lines (prionless HpL3.4 cells, HpL3.4 cells transfected with a Prnp vector, HpL3.4 cells transfected with a void vector, wild-type Hw3.5 Prnp(+/+) cells) expressed the murine homologue (Tage4) of human poliovirus receptor (CD155/hPVR). PV-1 infection of Prnp(-/-) HpL3.4 cells resulted in the production of high viral titers, though viral antigens could be detected in only 0.5% to 2% of cells. Wild-type Prnp(+/+) cells and prionless cells transfected with the Prnp gene were not permissive to PV-1. Results of viral titration and immunofluorescence were confirmed by conventional polymerase chain reaction (PCR) and quantitative real-time PCR. Exposure to PV-1 had no influence on the gene expression profile of Prnp(+/+) cells. In contrast, PV-1 infection was associated with upregulation of several genes in permissive Prnp(-/-) cell cultures: type I interferon (IFN) genes, IFN-related developmental regulator 1 (IFNRD1), tumor necrosis factor superfamily member 13b (TNFSF13b), interleukin (IL) - 7, granulocyte/macrophage colony-stimulating factors (CSFs), hepatocyte growth factor (HGF), vascular endothelial growth factor-A, transforming growth factors beta1 and beta3 (TGFb1, TGFb3), as well as a variety of bone morphogenetic proteins endowed with neuroprotective activity. Distinction of permissive from nonpermissive neuronal cells on the basis of Prnp expression suggests that prion-deficient mice could represent an extraordinarily sensitive animal model for poliovirus infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16036803     DOI: 10.1080/13550280590952745

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  46 in total

1.  Consequences of manganese replacement of copper for prion protein function and proteinase resistance.

Authors:  D R Brown; F Hafiz; L L Glasssmith; B S Wong; I M Jones; C Clive; S J Haswell
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

2.  Prions prevent neuronal cell-line death.

Authors:  C Kuwahara; A M Takeuchi; T Nishimura; K Haraguchi; A Kubosaki; Y Matsumoto; K Saeki; Y Matsumoto; T Yokoyama; S Itohara; T Onodera
Journal:  Nature       Date:  1999-07-15       Impact factor: 49.962

3.  Temporal and spatial gene expression patterns after experimental stroke in a rat model and characterization of PC4, a potential regulator of transcription.

Authors:  Adrian Roth; Ramanjit Gill; Ulrich Certa
Journal:  Mol Cell Neurosci       Date:  2003-03       Impact factor: 4.314

4.  Changes in the localization of brain prion proteins during scrapie infection.

Authors:  S J DeArmond; W C Mobley; D L DeMott; R A Barry; J H Beckstead; S B Prusiner
Journal:  Neurology       Date:  1987-08       Impact factor: 9.910

5.  Acceleration of scrapie disease in mice by an adenovirus.

Authors:  D W Ehresmann; R N Hogan
Journal:  Intervirology       Date:  1986       Impact factor: 1.763

6.  The neuropathology observed in wild-type mice inoculated with human poliovirus mirrors human paralytic poliomyelitis.

Authors:  Dayton J Ford; Stacie L Ropka; George H Collins; Burk Jubelt
Journal:  Microb Pathog       Date:  2002-09       Impact factor: 3.738

7.  Characterization and identification of Tage4 as the murine orthologue of human poliovirus receptor/CD155.

Authors:  Inga Ravens; Sebastian Seth; Reinhold Förster; Günter Bernhardt
Journal:  Biochem Biophys Res Commun       Date:  2003-12-26       Impact factor: 3.575

8.  Regional differences in viral growth and central nervous system injury correlate with apoptosis.

Authors:  Sarah M Richardson-Burns; Kenneth L Tyler
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Transfection of prion protein gene suppresses coxsackievirus B3 replication in prion protein gene-deficient cells.

Authors:  Yuko Nakamura; Akikazu Sakudo; Keiichi Saeki; Tomomi Kaneko; Yoshitsugu Matsumoto; Antonio Toniolo; Shigeyoshi Itohara; Takashi Onodera
Journal:  J Gen Virol       Date:  2003-12       Impact factor: 3.891

10.  DNAM-1 and PVR regulate monocyte migration through endothelial junctions.

Authors:  Nicolas Reymond; Anne-Marie Imbert; Elisabeth Devilard; Stéphanie Fabre; Christian Chabannon; Luc Xerri; Catherine Farnarier; Claudia Cantoni; Cristina Bottino; Alessandro Moretta; Patrice Dubreuil; Marc Lopez
Journal:  J Exp Med       Date:  2004-05-10       Impact factor: 14.307

View more
  3 in total

1.  Differential regulation and function of 5'-untranslated GR-exon 1 transcripts.

Authors:  Yvonne Bockmühl; Christopher A Murgatroyd; Arleta Kuczynska; Ian M Adcock; Osborne F X Almeida; Dietmar Spengler
Journal:  Mol Endocrinol       Date:  2011-04-28

Review 2.  Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP.

Authors:  Akikazu Sakudo; Takashi Onodera
Journal:  Front Cell Dev Biol       Date:  2015-01-15

3.  Prion Protein PRNP: A New Player in Innate Immunity? The Aβ Connection.

Authors:  Richard Lathe; Jean-Luc Darlix
Journal:  J Alzheimers Dis Rep       Date:  2017-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.